Pan-American migraine prevalence: Findings from the Americas’ migraine observatory study (AMIGOS)
Cephalalgia · 2026-03 · 46 (3)
DOI: 10.1177/03331024261420837 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cephalalgia, online erschienen am 06.03.2026. Verfasst von Marco Lisicki und 16 weiteren Autor:innen. Beteiligte Einrichtung: Headache Research Laboratory, Mercedes and Martín Ferreyra Institute for Medical Research (INIMEC), National Scientific and Technical Research Counci…. Hauptthemen laut MEDLINE: Migraine Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Pfizer Brazil.
Abstract (Originalsprache)
Introduction
Analyzing the epidemiology of headache disorders is fundamental for understanding their behaviour and designing effective public health strategies. Epidemiologic studies conducted in individual countries often lack consistent methodologies, limiting broader interpretation. The Americas’ Migraine Observatory Study (AMIGOS) is a Pan-American epidemiological study designed to evaluate the burden and access to treatment of migraine and other headache disorders across the Americas. Here, we present data on migraine prevalence and disability.
Objectives
To describe and compare the prevalence and burden of migraine in the Americas at a specific time point using a unified sampling methodology. Additionally, to identify regional variations and potential factors contributing to differences in prevalence, providing a foundation for targeted public health strategies. Materials and Methods Data were collected online or via telephone from a sample representative of the demographic and social characteristics of each country, with a confidence level of 98% and a margin of error of 5%. We conducted both qualitative and quantitative research on key aspects of headaches among 16,202 individuals in 19 countries from Canada to Chile. Migraine diagnosis was made based on the ICHD-3 criteria.
Results
The overall prevalence of migraine was 9.7% (13.2% among females, 6.5% among males). The highest prevalence was observed in Brazil (13.8%), Canada (13.2%), and the United States (12.7%), while the lowest prevalence was found in Bolivia (5.5%), Paraguay (7.1%), and Argentina (7.3%). Participants typically experienced 4 headache days per month, and chronic migraine prevalence was estimated at 1.3%. The migraine burden, as measured by Years Lived with Disability (YLDs), was highest in the United States.
Conclusion
This is the first comprehensive Pan-American migraine epidemiological study. Findings indicate that migraine is highly prevalent in the Americas, with significant variations among different countries. Genetic, socioeconomic, and environmental factors may explain these observed differences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Headache Research Laboratory, Mercedes and Martín Ferreyra Institute for Medical Research (INIMEC), National Scientific and Technical Research Council (CONICET), National University of Córdoba, Córdoba, Argentina.
- Biomedical Physics Department, School of Medicine, National University of Córdoba (UNC), Córdoba, Argentina.
- Universidad Siglo 21, Córdoba, Argentina.
- Hospital Universitario Mayor Mederi - Universidad del Rosario, Bogotá, Colombia.
- Centro Universitário de Volta Redonda - UniFOA, Volta Redonda, Brazil.
- Pfizer, São Paulo, Brazil.
ORCID-Profile: Marco Lisicki, Joe Muñoz-Cerón, Elder Machado Sarmento, Arao B Oliveira, Marcelo Moraes Valença, Juliana Ramos de Andrade, Karina Vélez-Jiménez, Ildefonso Rodriguez-Leyva, Ernesto Bancalari, Mario F P Peres
Förderung
- Pfizer Brazil
Zitieren
APA
Lisicki, M., Muñoz-Cerón, J., Sarmento, E. M., Ribeiro, A. P., Dantas, A. C. A., do Prado, L. L., de Nunes, A. K., Oliveira, A. B., Valença, M. M., de Andrade, J. R., Vélez-Jiménez, K., Rodriguez-Leyva, I., Giacomozzi, A. R. E., Bancalari, E., Juliet, R., Schubaroff, P., & Peres, M. F. P. (2026). Pan-American migraine prevalence: Findings from the Americas’ migraine observatory study (AMIGOS). Cephalalgia, 46(3). https://doi.org/10.1177/03331024261420837
Vancouver
Lisicki M, Muñoz-Cerón J, Sarmento EM, Ribeiro AP, Dantas ACA, do Prado LL, et al. Pan-American migraine prevalence: Findings from the Americas’ migraine observatory study (AMIGOS). Cephalalgia. 2026;46(3). doi:10.1177/03331024261420837
BibTeX
@article{Lisicki2026,
author = {Lisicki, Marco and Muñoz-Cerón, Joe and Sarmento, Elder Machado and Ribeiro, Adriana Polycarpo and Dantas, Ana Carolina de Assis and do Prado, Leandro Lara and de Nunes, Ana Karolina and Oliveira, Arao B and Valença, Marcelo Moraes and de Andrade, Juliana Ramos and Vélez-Jiménez, Karina and Rodriguez-Leyva, Ildefonso and Giacomozzi, Alex Rodrigo Espinoza and Bancalari, Ernesto and Juliet, Raúl and Schubaroff, Pablo and Peres, Mario F P},
title = {Pan-American migraine prevalence: Findings from the Americas’ migraine observatory study (AMIGOS)},
journal = {Cephalalgia},
year = {2026},
volume = {46},
number = {3},
doi = {10.1177/03331024261420837}
}
EUVIMED